Skip to content
knowrare
HealthSignal
Your condition community

Living with Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness

A rare inherited condition with a type of anemia that responds to vitamin B1, plus diabetes and hearing loss.

Understanding Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness

Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare inherited condition with hearing loss, diabetes, and a blood disorder called megaloblastic anemia.

In megaloblastic anemia there are few red blood cells and they are larger than normal. It usually develops between infancy and adolescence. The anemia can be treated with daily vitamin B1 (thiamine). Hearing loss usually starts in early childhood and tends to worsen. Diabetes often begins early, and insulin is usually needed. Some people have eye differences such as optic atrophy.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Megaloblastic anemia
  • Hearing loss from the inner ear
  • Diabetes
  • Paleness and low energy
  • Headache and poor appetite
  • Tingling or numbness in the hands and feet

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include blood and bone marrow specialists, ear, nose, and throat specialists, genetic specialists and hormone specialists.

  3. Consider genetic testing

    Changes in SLC19A2 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Blood and bone marrow specialists (hematologists); Ear, nose, and throat specialists (otolaryngologists); Genetic specialists (geneticists); Hormone specialists (endocrinologists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with rare disease patient organizations for support
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
How much thiamine should we use and how will it be monitored?
Could thiamine help hearing or delay diabetes in our case?
How often should the eyes and heart be checked?

Quick facts

Symptoms usually startChild
InheritanceAutosomal Recessive
GenesSLC19A2

Changes in the SLC19A2 gene cause this condition. It is autosomal recessive, meaning a child inherits a changed copy of the gene from each parent.

GeneticEndocrineBloodInherited Metabolic

Also known as: rogers syndrome; thiamine metabolism dysfunction syndrome 1; thiamine metabolism dysfunction syndrome 1 (megaloblastic anemia, diabetes mellitus, and deafness type); thiamine-responsive anaemia syndrome; thiamine-responsive anemia syndrome; thiamine-responsive megaloblastic anaemia with diabetes mellitus and sensorineural deafness

Patient organizations

Rare-disease groups that can help

Source: NIH GARD · Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafnessGARD ID 9210 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness.

Explore the Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness blog

Explore research for Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness

Explore actively recruiting Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.